| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| McCall Patrick | CHIEF FINANCIAL OFFICER | C/O IN8BIO, INC., 350 5TH AVE. SUITE 5330, NEW YORK | /s/ William Ho, Attorney-in-Fact | 23 Dec 2025 | 0001874384 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INAB | Common Stock | Award | $10,001 | +7,247 | +324% | $1.38 | 9,482 | 22 Dec 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Effective June 3, 2025, the Issuer effected a 1-for-30 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. |